175 related articles for article (PubMed ID: 36923593)
1. Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs.
Vu K; Buckley BJ; Bujaroski RS; Blumwald E; Kelso MJ; Gelli A
Front Cell Infect Microbiol; 2023; 13():1101568. PubMed ID: 36923593
[TBL] [Abstract][Full Text] [Related]
2. The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na
Vu K; Blumwald E; Gelli A
Front Microbiol; 2021; 12():673035. PubMed ID: 34025629
[TBL] [Abstract][Full Text] [Related]
3. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
4.
Tetz G; Collins M; Vikina D; Tetz V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
[TBL] [Abstract][Full Text] [Related]
5. Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization.
Ianiri G; Idnurm A
mBio; 2015 Mar; 6(2):. PubMed ID: 25827419
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
[TBL] [Abstract][Full Text] [Related]
7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
8. Enhanced fungal specificity and
Rivera A; Young Lim W; Park E; Dome PA; Hoy MJ; Spasojevic I; Sun S; Averette AF; Pina-Oviedo S; Juvvadi PR; Steinbach WJ; Ciofani M; Hong J; Heitman J
mBio; 2023 Oct; 14(5):e0181023. PubMed ID: 37737622
[TBL] [Abstract][Full Text] [Related]
9. Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates.
Montoya MC; Beattie S; Alden KM; Krysan DJ
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907188
[TBL] [Abstract][Full Text] [Related]
10. Repurposing an inhibitor of ribosomal biogenesis with broad anti-fungal activity.
Sun N; Li D; Zhang Y; Killeen K; Groutas W; Calderone R
Sci Rep; 2017 Dec; 7(1):17014. PubMed ID: 29209049
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibility testing.
Hoffman HL; Pfaller MA
Pharmacotherapy; 2001 Aug; 21(8 Pt 2):111S-123S. PubMed ID: 11501985
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
Pfaller MA; Messer SA; Hollis RJ; Jones RN
Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
[TBL] [Abstract][Full Text] [Related]
13. Development and research progress of anti-drug resistant fungal drugs.
Cui X; Wang L; Lü Y; Yue C
J Infect Public Health; 2022 Sep; 15(9):986-1000. PubMed ID: 35981408
[TBL] [Abstract][Full Text] [Related]
14. Cinnamyl Schiff bases: synthesis, cytotoxic effects and antifungal activity of clinical interest.
Magalhães TFF; da Silva CM; Dos Santos LBF; Santos DA; Silva LM; Fuchs BB; Mylonakis E; Martins CVB; de Resende-Stoianoff MA; de Fátima Â
Lett Appl Microbiol; 2020 Nov; 71(5):490-497. PubMed ID: 32777092
[TBL] [Abstract][Full Text] [Related]
15. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).
Castanheira M; Messer SA; Rhomberg PR; Pfaller MA
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):200-4. PubMed ID: 27061369
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of in vitro antifungal susceptibility testing.
Espinel-Ingroff A
Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
[TBL] [Abstract][Full Text] [Related]
18. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Lead 2-Thiazolylhydrazones with Broad-Spectrum and Potent Antifungal Activity.
Oliveira NJC; Dos Santos Júnior VS; Pierotte IC; Leocádio VAT; Santana LFA; Marques GVL; Protti ÍF; Braga SFP; Kohlhoff M; Freitas TR; Sabino AP; Kronenberger T; Gonçalves JE; Johann S; Santos DA; César IDC; Maltarollo VG; Oliveira RB
J Med Chem; 2023 Dec; 66(24):16628-16645. PubMed ID: 38064359
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of topical microemulsion containing a thiophene derivative.
Guimarães GP; de Freitas Araújo Reis MY; da Silva DT; Junior FJ; Converti A; Pessoa A; de Lima Damasceno BP; da Silva JA
Braz J Microbiol; 2014; 45(2):545-50. PubMed ID: 25242940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
